Welcome to the 2026 EASL Liver Cancer Summit in Edinburgh, the leading event for liver cancer research and clinical practice.
Rapid advancements in hepatocellular carcinoma and cholangiocarcinoma are transforming treatment strategies, with immunotherapy, new systemic therapies, and AI-driven diagnostics reshaping the field. This summit offers a unique opportunity to engage with experts across disciplines, explore the latest in basic, translational, and clinical research, and address evolving standards in personalised care.
EASL Liver Cancer Summit 2026 (EASL LCS 2026) took place in Edinburgh, Scotland, UK, 22–24 January 2026. This edition has ended. Congress Bookers lists the next edition as soon as it is announced.